YONEKA POWELL: Open Payments
NPI 1689191017 · LEESBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,677 in 54 payments from 11 companies in 2025. Trend: 2023 $1,912 · 2024 $1,370 · 2025 $1,677
Food & beverage: $1,565Education: $111
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $450 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $447 |
| Teva Pharmaceuticals USA, Inc. | 5 | $190 |
| Vanda Pharmaceuticals Inc. | 6 | $173 |
| Alkermes, Inc. | 6 | $151 |
| Axsome Therapeutics, Inc. | 3 | $70 |
| Otsuka America Pharmaceutical, Inc. | 3 | $64 |
| Supernus Pharmaceuticals, Inc. | 3 | $48 |
| Collegium Pharmaceutical, Inc. | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
Products named: VRAYLAR, CAPLYTA, FANAPT, LYBALVI, AUSTEDO XR, Auvelity, REXULTI, Qelbree.
Industry payments across FL — which companies pay providers there.
